These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 31504527)

  • 1. Application of Herbaceous Medications for Inflammatory Bowel Disease as a Complementary and Alternative Therapy.
    Lin Z; Wu H; Fu Y; Dai S
    Inflamm Bowel Dis; 2019 Nov; 25(12):1886-1895. PubMed ID: 31504527
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Complementary Therapies in Inflammatory Bowel Diseases.
    Yanai H; Salomon N; Lahat A
    Curr Gastroenterol Rep; 2016 Dec; 18(12):62. PubMed ID: 27747459
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Complementary and alternative medicine in inflammatory bowel diseases: what is the future in the field of herbal medicine?
    Gilardi D; Fiorino G; Genua M; Allocca M; Danese S
    Expert Rev Gastroenterol Hepatol; 2014 Sep; 8(7):835-46. PubMed ID: 24813226
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effectiveness and safety of curcumin as a complementary therapy in inflammatory bowel disease: A protocol of systematic review and meta-analysis.
    Yang Z; Liu W; Zhou X; Zhu X; Suo F; Yao S
    Medicine (Baltimore); 2020 Oct; 99(43):e22916. PubMed ID: 33120843
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Systematic review of complementary and alternative medicine treatments in inflammatory bowel diseases.
    Langhorst J; Wulfert H; Lauche R; Klose P; Cramer H; Dobos GJ; Korzenik J
    J Crohns Colitis; 2015 Jan; 9(1):86-106. PubMed ID: 25518050
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comprehensive study on the administrative, economic, regional, and regulatory prospects of complementary and alternative medicine (CAM) in inflammatory bowel disease (IBD).
    Mousavi T; Nikfar S; Abdollahi M
    Expert Rev Clin Pharmacol; 2021 Jul; 14(7):865-888. PubMed ID: 33993811
    [No Abstract]   [Full Text] [Related]  

  • 7. Characterisation of complementary and alternative medicine use and its impact on medication adherence in inflammatory bowel disease.
    Weizman AV; Ahn E; Thanabalan R; Leung W; Croitoru K; Silverberg MS; Steinhart AH; Nguyen GC
    Aliment Pharmacol Ther; 2012 Feb; 35(3):342-9. PubMed ID: 22176478
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Complementary therapies in inflammatory bowel diseases.
    Esters P; Dignass A
    Curr Drug Targets; 2014; 15(11):1079-88. PubMed ID: 25182607
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Complementary and Alternative Medicine Use in Children With Inflammatory Bowel Disease.
    Phatak UP; Alper A; Pashankar DS
    J Pediatr Gastroenterol Nutr; 2019 Feb; 68(2):157-160. PubMed ID: 30499887
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Review on efficacy and health services research studies of complementary and alternative medicine in inflammatory bowel disease.
    Joos S
    Chin J Integr Med; 2011 Jun; 17(6):403-9. PubMed ID: 21660673
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Use of complementary and alternative medicine (CAM) in patients with inflammatory bowel disease (IBD): results from a German nationwide survey of 2019 compared to a previous survey of 2002.
    Bauer N; Kairey L; Schlee C; Uecker C; Öznur Ö; Langhorst J
    Scand J Gastroenterol; 2022 Oct; 57(10):1209-1215. PubMed ID: 35722930
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Use of complementary and alternative medicine in Swedish patients with inflammatory bowel disease: a controlled study.
    Oxelmark L; Lindberg A; Löfberg R; Sternby B; Eriksson A; Almer S; Befrits R; Fossum B; Karlén P; Broström O; Tysk C;
    Eur J Gastroenterol Hepatol; 2016 Nov; 28(11):1320-8. PubMed ID: 27472271
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Complementary and Alternative Medicine.
    Quezada SM; Briscoe J; Cross RK
    Inflamm Bowel Dis; 2016 Jun; 22(6):1523-30. PubMed ID: 27057686
    [TBL] [Abstract][Full Text] [Related]  

  • 14. European Crohn's and Colitis Organisation Topical Review on Complementary Medicine and Psychotherapy in Inflammatory Bowel Disease.
    Torres J; Ellul P; Langhorst J; Mikocka-Walus A; Barreiro-de Acosta M; Basnayake C; Ding NJS; Gilardi D; Katsanos K; Moser G; Opheim R; Palmela C; Pellino G; Van der Marel S; Vavricka SR
    J Crohns Colitis; 2019 May; 13(6):673-685e. PubMed ID: 30820529
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Predictive factors of complementary and alternative medicine use for patients with inflammatory bowel disease in Korea.
    Park DI; Cha JM; Kim HS; Park HJ; Shin JE; Hong SN; Hong SS; Kim WJ
    Complement Ther Med; 2014 Feb; 22(1):87-93. PubMed ID: 24559822
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Complementary and alternative medicine use by Canadian patients with inflammatory bowel disease: results from a national survey.
    Hilsden RJ; Verhoef MJ; Best A; Pocobelli G
    Am J Gastroenterol; 2003 Jul; 98(7):1563-8. PubMed ID: 12873578
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Review article: complementary and alternative therapies for inflammatory bowel disease.
    Langmead L; Rampton DS
    Aliment Pharmacol Ther; 2006 Feb; 23(3):341-9. PubMed ID: 16422993
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Treatment adherence and use of complementary and alternative medicine in patients with inflammatory bowel disease].
    Lakatos L; Czeglédi Z; Dávid G; Kispál Z; Kiss LS; Palatka K; Kristóf T; Molnár T; Salamon A; Demeter P; Miheller P; Szamosi T; Banai J; Papp M; Bene L; Kovács A; Rácz I; Lakatos PL
    Orv Hetil; 2010 Feb; 151(7):250-8. PubMed ID: 20133244
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Use of complementary and alternative medicine by patients with inflammatory bowel disease.
    Hilsden RJ; Verhoef MJ; Rasmussen H; Porcino A; DeBruyn JC
    Inflamm Bowel Dis; 2011 Feb; 17(2):655-62. PubMed ID: 20848543
    [TBL] [Abstract][Full Text] [Related]  

  • 20. COMPLEMENTARY AND ALTERNATIVE MEDICINE USE IN BRAZILIAN PATIENTS WITH INFLAMMATORY BOWEL DISEASE.
    Henriques DP; Oliveira RR; Vanni J; Lima HP; Otiti JV; Neves FRM; Hammerle MB; Sassaki LY; Zaltman C
    Arq Gastroenterol; 2022; 59(3):375-382. PubMed ID: 36102435
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.